Oura Health Files for Nasdaq IPO, Valuing Smart Ring Market at $16 Billion Amidst Intensifying Competition

Oura Health, the trailblazing company that largely defined the smart ring category, has formally initiated its path to a public listing on Nasdaq under the ticker OURA, filing its S-1 registration statement with the U.S. Securities and Exchange Commission on September 3, 2026. This pivotal move targets a valuation exceeding $16 billion, with aspirations to raise up to $3 billion from the offering, signaling a monumental validation of the smart ring market as it transitions from a niche wearable to a mainstream health monitoring device.

The financial health underpinning Oura's IPO is robust; the company reported $1.21 billion in revenue for the nine months ended June 30, 2026, marking a substantial 74% increase year-over-year. This follows a full fiscal 2025 revenue of $907.9 million, which itself saw a 123% surge from fiscal 2024. Bolstering this growth, Oura's paid membership base doubled to 5.0 million by mid-2026, from 2.5 million a year prior, demonstrating strong customer acquisition and retention. With Oura holding between 79% and 85% of global smart ring shipments in recent quarters, its public offering is not merely a corporate milestone but a definitive statement on the smart ring's established presence and future potential. The recent launch of the Oura Ring 5 in May 2026, which is 40% smaller than its predecessor and introduces advanced features like blood pressure trend detection, nighttime breathing analysis, and GLP-1 medication tracking, underscores Oura's commitment to continuous innovation. Furthermore, a significant 72% of Oura's 5 million paid members are women, positioning the company to expand deeply into women's health, including fertility, pregnancy, and menopause tracking. However, the reliance on a subscription model—priced at $5.99 monthly or $69.99 annually for full features beyond basic readiness, sleep, and activity scores—remains a core part of its business strategy and a point of differentiation from many emerging rivals.

Oura's public debut arrives amidst an intensifying competitive landscape, as numerous companies vie for a slice of the burgeoning smart ring market, each employing distinct strategies to gain an edge. Ultrahuman, for instance, offers its Ring AIR for $349, notably without a monthly subscription for its core features, directly challenging Oura's recurring revenue model. The Ultrahuman Ring AIR distinguishes itself with an ultra-lightweight design (2.4-3.6 grams), a durable titanium shell reinforced with tungsten carbide carbon coating, and a focus on detailed sleep, recovery, circadian rhythm, and a dynamic recovery score that adjusts throughout the day. Despite offering optional paid "PowerPlugs" for specialized features like a women's health module for $39.99 per year, Ultrahuman faces challenges with U.S. availability due to an ITC exclusion order stemming from Oura's patent litigation, effective October 2025.

Another formidable contender, RingConn, introduced its Gen 3 smart ring at CES 2026 and showcased it at IFA 2026, retailing for $349, with brushed finishes at $369, also operating on a subscription-free model. The RingConn Gen 3 boasts an ultra-thin 2.3mm profile and lightweight design (2.5-3.5g), making it one of the slimmest and most comfortable options available. It offers an impressive battery life of up to 14 days and introduces vibration alerts for health notifications and sedentary reminders. Crucially, the Gen 3 now includes preliminary blood pressure and sleep apnea detection, though these features are not yet FDA-cleared. The inclusion of a travel charging case that provides over 150 days of battery life further enhances its appeal for users prioritizing convenience and extended use.

Movano Health's Evie Ring targets a specific demographic, designed explicitly for women's health, and is priced at $269 with no subscription required. The Evie Ring tracks essential metrics like menstrual cycles, ovulation, symptoms, mood, heart rate, and sleep patterns, providing a holistic view of women's health. Its open and flexible design accommodates natural finger size fluctuations, and Movano is actively seeking FDA clearance for its heart rate and SpO2 tracking features, aiming for medical-grade accuracy.

In the budget segment, the Amazfit Helio Ring stands out at $199, having dropped from its initial $299 price, and also offers a subscription-free experience. This titanium alloy ring, weighing under 4 grams and 2.6mm thick, provides basic sleep and health tracking, including electrodermal activity-based stress detection, with a 4-day battery life. While its size offerings are limited to 8, 10, and 12, it presents a compelling entry point for consumers seeking core smart ring functionalities without a premium price tag or ongoing fees.

The entry of tech giants further complicates the competitive landscape. Samsung launched its Galaxy Ring in April 2024, emphasizing seamless integration with its Galaxy ecosystem. While the initial Galaxy Ring offers a slim titanium design and around 3-4 days of battery life, it has been seen more as a companion to the Galaxy Watch than a direct Oura rival. However, Samsung has confirmed the development of the Galaxy Ring 2 for an early 2027 launch, promising improved sensor performance and battery life, aiming to be a more formidable contender. Apple, too, is rumored to be developing an "iRing," with speculation re-emerging in June 2026, suggesting a potential launch as early as September 2026 alongside the iPhone 18. Patents hint at gesture-based control for the Apple ecosystem, and with Apple's head of digital health, Eddy Cue, pushing for more aggressive health offerings, an Apple smart ring could present a significant threat, potentially offering a more affordable alternative to the Apple Watch.

The smart ring market is clearly heading towards diversification and specialization. This heightened competition benefits users through more choices, potentially lower prices, and features tailored to specific needs, such as women's health or medical-grade tracking. For the industry, it accelerates innovation, pushing companies to refine sensor accuracy, improve battery life, and enhance data insights. The future will likely see further consolidation as smaller players are acquired or struggle to compete with the ecosystems of tech giants. Oura's challenge will be to maintain its innovation lead and user trust while fending off rivals offering subscription-free models and the immense marketing power of companies like Samsung and potentially Apple. The smart ring is no longer just a gadget; it is rapidly evolving into a sophisticated, ubiquitous health monitoring device, fundamentally altering how individuals engage with their personal health data.